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Hemoglobin A1c (HbA1c) levels are indicators for managing Diabetes Mellitus.
This study investigated the effectiveness of Diabetes Mellitus education classes based on
participants’ HbA1c levels. The HbA1c and body mass index (BMI) values were
analyzed using t-tests to determine significant (P ≤ 0.05) differences between baseline (N
= 46) levels compared to three months, six months, and 12 months after class
participation and reported as means ± standard deviations. The study was not able to
track all participants as some did not attend all follow-up sessions. Mean HbA1c levels
were lower at three months (8.1% ± 2.1, P = 0.002, n = 31), six months (8.11% ± 2.6, P =
0.001, n = 39), and 12 months (8.7% ± 2.3, P = 0.050, n = 29) compared to baseline
(9.5% ± 2.4). The baseline BMI was 36.7kg/m2 ± 9.7 with similar (P > 0.05) values after
class attendance.
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CHAPTER I
INTRODUCTION

Nationally, Diabetes Mellitus affected 25.8 million Americans in 2010 (Centers
for Disease Control and Prevention, 2011). Approximately 18.8 million people were
diagnosed and seven million were undiagnosed with Diabetes Mellitus in the United
States during 2010 (Centers for Disease Control and Prevention, 2011). While the
national prevalence of Diabetes Mellitus was 8.4% for adults aged 30 to 59 years and
23.6% for those aged 60 years and older, Mississippi had a higher prevalence rate of
11.4% in adults aged 30 to 59 years and 27.7% for those aged 60 years and older (Danaei,
Friedman, Oza, Murray, & Ezzati, 2009).
Diabetes Mellitus is a metabolic disease characterized by high blood glucose
concentrations, or hyperglycemia, resulting from defects in insulin secretion, insulin
action, or both (American Diabetes Association, 2011a). This disease is manifested as
Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus, or Gestational Diabetes Mellitus.
Type 2 Diabetes Mellitus accounts for 90 to 95 percent of diagnosed cases and is
associated with insulin resistance in the target tissues, mainly muscle, liver, and adipose
cells (Franz, 2008). As Type 2 Diabetes Mellitus progresses, production of insulin from
the pancreas decreases. Approximately 40% of people with Type 2 Diabetes Mellitus
eventually require insulin therapy for adequate blood glucose control (Franz, 2008).
1

Medical nutrition therapy is paramount for managing Diabetes Mellitus. There is
not a specific diet that best manages Diabetes Mellitus; instead the focus should be on an
individualized nutrition prescription that considers the patient’s culture, lifestyle
preferences, and overall quality of life. For medical nutrition therapy to be effectively
administered, it should be a team approach with doctors, nurses, pharmacists, and
dietitians all working together to provide optimal care for people with Diabetes Mellitus.
When medical nutrition therapy is provided in combination with self management, a
decrease in glycosylated hemoglobin A1c (HbA1c) occurs by one to two percentage
points in people with Type 2 Diabetes Mellitus (Lemon et al., 2004; Pastors, Franz,
Warshaw, Daly, & Arnold. 2003). The goals of medical nutrition therapy are to (1)
achieve HbA1c levels below seven percent, (2) achieve blood pressure levels within the
normal range, and (3) achieve lipid profiles in healthy ranges to reduce the risk of
cardiovascular disease (American Diabetes Association, 2007a). People with Diabetes
Mellitus are encouraged to adjust their lifestyle and intake of foods and beverages to
prevent the development of chronic diseases (American Diabetes Association, 2007a).
With the number of cases of Diabetes Mellitus expected to increase by 165% by
the year 2050 in the United States (Diabetes Foundation of Mississippi, 2010), it is
important to deliver programs that help people with Diabetes Mellitus effectively manage
their disease, especially in Mississippi. Over 200,000 Mississippians have been
diagnosed with Diabetes Mellitus; for every 100 Mississippians, approximately 8.9 are
living with Diabetes Mellitus (Kaiser Family Foundation, 2011). Mississippi has the
second highest prevalence of Diabetes Mellitus in the United States (Kaiser Family
Foundation, 2011) and effective Diabetes Mellitus education is needed to assist people in
2

controlling their Diabetes Mellitus and preventing long-term diabetic complications such
as kidney disease, neuropathy, and retinopathy which can lead to blindness (Franz, 2008).
This study evaluated the effectiveness of Diabetes Mellitus education provided by
the interdisciplinary team at the Diabetes Mellitus Education Class at North Mississippi
Medical Center-Eupora (NMMC-Eupora). The purpose of the study was to compare
HbA1c levels prior to participants attending Diabetes Mellitus Education Class and again
at three months, six months, and 12 months after attending the class. The objective was to
compare the outcomes between each of the HbA1c levels to determine the effectiveness
of Diabetes Mellitus education as related to HbA1c levels. Body mass index (BMI)
values were evaluated at baseline, three months, six months, and 12 months to determine
if participants were experiencing changes in weight as they managed their Diabetes
Mellitus.
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CHAPTER II
REVIEW OF LITERATURE

National Prevalence of Diabetes Mellitus
Although Diabetes Mellitus is diagnosed in approximately 18.8 million
Americans, there are an estimated seven million Americans who have diabetes and are
undiagnosed (Centers for Disease Control and Prevention, 2011). There are 25.6 million
cases of Diabetes Mellitus in people over the age of 20 years, which is 11.3% of the
United States population (Centers for Disease Control and Prevention, 2011). Much of
what is considered to be the Southeastern region of the United States has a large
prevalence of Diabetes Mellitus (Figure 1).
T he likelihood of developing Diabetes Mellitus increases with age. Among the
American population over the age of 65 years, there are approximately 10.9 million
people living with Diabetes Mellitus, which accounts for approximately 26.9% of the
total population and just over one-fourth of the senior citizen population (Centers for
Disease Control and Prevention, 2011). For people over the age of 20 years, Diabetes
Mellitus is more prevalent in the male population with 13 million cases compared to 12.6
million cases of Diabetes Mellitus in females (Centers for Disease Control and
Prevention, 2011). Approximately 11.8% of all males and 10.8% of all females have
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Diabetes Mellitus in the United States (Centers for Disease Control and Prevention,
2011).

Figure 1.

Percentage Estimates of Adults Diagnosed with Diabetes Mellitus.

Source: Centers for Disease Control and Prevention, 2008a.
Diabetes Mellitus is a disease that discriminates against specific racial/ethnic
populations (Franz, 2008). After adjusting for population age differences, a national
survey from 2007-2009 indicated that 12.6% of non-Hispanic blacks, 11.8% of
Hispanics, 8.4% of Asian Americans, and 7.1% of non-Hispanic whites were diagnosed
5

with Diabetes Mellitus (Centers for Disease Control and Prevention, 2011). Sufficient
data were not available to determine the ratio of diagnosed to undiagnosed cases of
Diabetes Mellitus for all minority groups. When compared to non-Hispanic white adults,
the minority groups were at increased risk of developing Diabetes Mellitus by 77%
among non-Hispanic blacks, 66% in Hispanics, and 18% in Asian Americans (Centers for
Disease Control and Prevention, 2011). Signorello et al. (2007) noted that while there are
many reasons that have been stated for racial disparities in Diabetes Mellitus prevalence
including environmental, socioeconomic, physiological, and genetic contributors,
scientific evidence does not support race alone as a risk factor. They concluded that
analyses of 34,331 African American and 9,491 Caucasian adults suggested differences
in Diabetes Mellitus prevalence between African Americans and Caucasians may simply
reflect differences in socioeconomic status (Signorello et al., 2007).
The cost of Diabetes Mellitus care is expensive and a strain on the United States
health care system, and is expected to add more of a strain to an already overburdened
health care system (Huang, Basu, O’Grady, & Capretta, 2009). The total estimated cost
of Diabetes Mellitus in the United States in 2007 was 174 billion dollars (Centers for
Disease Control and Prevention, 2011). Health care costs of treating Diabetes Mellitus
are expected to at least double in the next 25 years to an annual spending rate of
approximately 336 billion dollars (in constant 2007 U.S. dollars) (Huang et al., 2009).

Mississippi Prevalence of Diabetes Mellitus
Mississippi has a high prevalence of Diabetes Mellitus (Figure 2). Of the
2,844,658 Mississippi residents, approximately 11.6% (206,000 Mississippians) have
6

been diagnosed with Diabetes Mellitus (Kaiser Family Foundation, 2011).
Approximately 9.7 in 100 people in Mississippi have Diabetes Mellitus (Kaiser Family
Foundation, 2011). The largest age group of Mississippians diagnosed with Diabetes
Mellitus is between the ages of 45 and 64 years, with approximately 90,000 confirmed
cases. Mississippians aged 65 and older account for approximately 74,000 cases of
Diabetes Mellitus. Diabetes Mellitus is beginning to affect younger generations, with
41,000 people under the age of 44 years having Diabetes Mellitus in Mississippi (Kaiser
Family Foundation, 2011).

Figure 2.

Percentage Estimates of Adults Diagnosed with Diabetes Mellitus in
Mississippi.

Source: Centers for Disease Control and Prevention, 2008b.
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Diabetes Mellitus was the seventh leading cause of death among Americans in
2007 (Centers for Disease Control and Prevention, 2011). In Mississippi, approximately
21.8 deaths per 100,000 were related to diabetic complications in Mississippi in 2007,
and the incidence of death of the African American population was 38.2 per 100,000 as
compared to 15.4 for the Caucasian population (Kaiser Family Foundation, 2011). The
risk of dying from a diabetic complication is twice as likely when compared to a healthy
individual of the same age that does not have Diabetes Mellitus (Centers for Disease
Control and Prevention, 2011). Signorello et al. (2007) stated that African American
adults are 50 to 100% more likely to have Diabetes Mellitus that Caucasians.
In Mississippi, only four of the 82 counties reported a 10 percent or less
prevalence of Diabetes Mellitus (Centers for Disease Control and Prevention, 2008a).
Specifically in Webster County, Mississippi, which has a population of 9,887 people,
11.1% of its residents are living with Diabetes Mellitus (Mississippi State Department of
Health, 2007). Diabetes Mellitus has been shown to affect the non-Caucasian population
more severely, causing 55.2 deaths per 100,000 as compared to 12 per 100,000 in the
Caucasian population in Webster County (Mississippi State Department of Health, 2007).
It is evident that Mississippi is experiencing an epidemic in Diabetes Mellitus.
Aggressive forms of treatment and prevention are needed throughout the state due to this
rising number of diabetic cases both diagnosed and undiagnosed.

Diabetes Mellitus
Diabetes Mellitus is a group of metabolic diseases characterized by a defect in
insulin secretion and/or insulin action (American Diabetes Association, 2011a). Diabetes
8

Mellitus is manifested as Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus, or
Gestational Diabetes Mellitus occurring during pregnancy. Type 2 Diabetes Mellitus is
much more common than Type 1 or Gestational and accounts for 90 to 95 percent of all
diagnosed cases (Franz, 2008). The focus of this thesis is on Type 2 Diabetes Mellitus.
Diabetes Mellitus affects how the body uses blood glucose, commonly known as
blood sugar; the body is unable to metabolize glucose properly (Franz, 2008). Glucose is
vital to a person’s health as one of the most important sources of energy used by muscle
cells and other tissues, and glucose is the brain’s main source of fuel (American Diabetes
Association, 2011a). A person diagnosed with Diabetes Mellitus, regardless of the type,
indicates there is too much glucose in the bloodstream and it is not being delivered into
the cells properly.
Glucose comes from the food we eat and is also naturally produced in the liver.
The liver acts as a glucose storage and manufacturing center when there is a lack of food
being ingested (American Diabetes Association, 2011a). During digestion and absorption,
glucose is absorbed into the bloodstream and glucose is able to enter the cells with the aid
of insulin. Specialized endocrine cells in the pancreas, the Islets of Langerhans, produce
hormones; the alpha cells produce glucagon, and the beta cells produce insulin which
decreases glucose levels in the blood. When a person eats, the pancreas secretes the
hormone insulin and it circulates throughout the bloodstream. Insulin acts like a key
which unlocks the doors to the cells that allow glucose to enter into the cells, and lowers
the amount of glucose in the bloodstream.
In most cases, Type 2 Diabetes Mellitus results from progressive defection in
insulin secretion that is coupled with insulin resistance and beta cell failure. The extent to
9

which insulin resistance and beta cell failure contribute to the development of Diabetes
Mellitus is still unclear (Franz, 2008). The cells of the body become resistant to the action
of insulin, and the pancreas is unable to produce enough insulin to overcome this
resistance. Glucose builds up in the bloodstream leading to hyperglycemia. While
endogenous insulin levels may be normal, depressed insulin levels are not able to
adequately overcome the insulin resistance of the cells (Franz, 2008). Increased hepatic
glucose production coupled with diminished glucose uptake and utilization, results in
insulin resistance occurring mainly in muscle, liver, and adipose cells (Chan &
Abrahamson, 2003).
Experimental evidence suggests that insulin resistance may be due to the
compromised synthesis or mobilization of the cells’ glucose transporters (Garvey et al.,
1991). Insulin resistance in the cells of skeletal muscle is caused by a reduction in
glucose transporter activity, specifically the failure of the vesicles to translocate the
response to insulin (Garvey et al., 1991). This can be thought of as a short circuit in the
insulin signal that typically initiates the glucose uptake process (Garvey et al., 1991). Due
to the defect of the binding insulin receptors, there is a decrease in the number of insulin
receptors, which reduces the action of the insulin receptors and decreases the uptake of
glucose (Franz, 2008). In the beginning stages of the disease, there are compensatory
increases in insulin secretion which aids in maintaining normal glucose concentrations
but with disease progression, insulin production gradually decreases (Franz, 2008).
Hyperglycemia first exhibits signs of being elevated in the post-prandial (after
meal) blood glucose, which is caused by a resistance to insulin at the cellular level and
then is followed by an elevation of fasting glucose concentrations (Franz, 2008). As the
10

disease progresses, insulin secretion decreases and the hepatic glucose production
increases, which cause elevated pre-prandial blood glucose levels prior to a meal (Franz,
2008).
Insulin resistance also occurs at the adipocyte level which leads to an increased
number of free fatty acids (Bergman & Adler, 2000). There is a depletion of mRNA
encoding the GLUT 4 transporter which results in a depletion of intracellular stores of
protein (Garvey et al., 1991). Protein synthesis is interfered with in the translocation
process leading to an inadequate number of surface receptors to uptake insulin, which
leads to lipolysis and an elevation in free circulating free fatty acids (Bergman & Adler,
2000). When there is an excess accumulation of visceral fat, intrabdominal obesity occurs
around the abdominal organs and leads to an increased flux of free fatty acids to the liver,
and insulin resistance (Bergman & Adler, 2000). Due to an increased number of fatty
acids, this can lead to a further decrease in insulin secretion and hepatic glucose
production known as lipotoxicty (Bergman & Adler, 2000). Obesity leads to insulin
resistance by reducing the GLUT 4 mRNA, which results in a decrease in the de nova
synthesis of the transporter (Garvey et al., 1991). The extent of mRNA suppression is
directly related to increased adiposity (Garvey et al., 1991).

Diagnosis of Diabetes Mellitus
Diagnosis of Diabetes Mellitus is based on blood glucose levels, which can be
measured by several tests. A fasting plasma glucose test measures the blood glucose of a
person who has fasted for at least eight hours; if the blood glucose level meets or exceeds
126 ml/dL on at least two separate occasions, then the diagnosis of Diabetes Mellitus is
11

made (Franz, 2008). This is the preferred test for diagnosing Diabetes Mellitus as it is
easy and cost efficient (Franz, 2008).
An oral glucose tolerance test measures the blood glucose levels of a person
fasting for at least eight hours. Blood glucose is measured two hours after consuming a
glucose-containing beverage. If the blood glucose level meets or exceeds 200 ml/dL,
Diabetes Mellitus is diagnosed (Franz, 2008). A random plasma glucose test measures the
blood glucose at any point during the day; if the blood glucose is 200 ml/dL or greater,
along with an assessment of diabetic symptoms such as excessive thirst (polydipsia),
frequent urination, weight loss, or excessive food intake/hunger (polyphagia), this
indicates a diagnosis of Diabetes Mellitus (Franz, 2008).
Any of these tests can suggest Diabetes Mellitus, but a positive test must be
confirmed by performing a second test on a later date (Franz, 2008). The American
Diabetes Association accepted the use of HbA1c as a diagnosis for Diabetes Mellitus in
2010 (American Diabetes Association, 2011b). When an HbA1c value, that is performed
in a laboratory certified by the National Glycohemoglobin Standardization Program, is
6.5% or greater, this indicates a diagnosis of Diabetes Mellitus (American Diabetes
Association, 2011b).

Hemoglobin A1c
Hemoglobin is a protein that links with sugar molecules inside red blood cells.
The HbA1c blood test reflects the blood glucose concentration over the life span of red
blood cells, which is approximately 120 days. The measure of HbA1c reflects a weighted
average of plasma glucose concentrations of red blood cells. This is expressed as a
12

percentage of total hemoglobin with glucose (American Diabetes Association, 2006).
When Diabetes Mellitus is uncontrolled, too much glucose is in the bloodstream and is
reflected by abnormally high HbA1c levels.
The normal HbA1c for people without Diabetes Mellitus is four to six percent
(Franz, 2008). Each one percent increase in HbA1c reflects an average increase of
approximately 30ml/dL in blood glucose (Table 1). Higher glycated hemoglobin
correlates with higher levels of glucose in the blood (American Diabetes Association,
2006). Elevated HbA1c levels indicate that blood glucose levels have been above normal
over a period of weeks or months. It is important for people with Diabetes Mellitus to
maintain HbA1c levels below seven percent to reduce the risk of complications
associated with Diabetes Mellitus such as eye disease, heart disease, kidney disease,
nerve damage and stroke (American Diabetes Association, 2006). Fasting blood glucose
levels should not exceed 130 mg/dL and the goal for post-prandial blood glucose is less
than 180 mg/dL (Table 2) (American Diabetes Association, 2007b).
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Table 1.

HbA1c Levels and Corresponding Mean Blood Glucose Levels
HbA1c (%)

Mean Blood Glucose (mg/dL)

5.0

100

6.0

120

7.0

150

8.0

180

9.0

210

10.0

240

11.0

270

Source: Franz, 2008.

Table 2.

Recommendations for Glycemic Control for Adults with Diabetes Mellitus
Glucose Control

Normal Values

HbAlc

< 7.0%

Pre-prandial plasma glucose

90 – 130 mg/dL

Post-prandial plasma glucose

< 180 mg/dL

Source: American Diabetes Association, 2007b.

Risk Factors for Diabetes Mellitus
Type 2 Diabetes Mellitus has distinguishing characteristics that make some
people more at risk for developing Diabetes Mellitus compared to other people. A person
with a history of impaired fasting glucose or impaired glucose tolerance has an increased
risk of developing Type 2 Diabetes Mellitus (Escott-Stump, 2008).

14

Age and Gender
Most people, male and female, are over the age of 45 when they develop Type 2
Diabetes Mellitus, although it is now occurring frequently in young adults and even in
children (Escott-Stump, 2008). This may be attributed to the fact that as one ages, there is
a tendency to exercise less, lose muscle mass, and gain weight (American Diabetes
Association, 2011a). A family history that includes parents or siblings with Diabetes
Mellitus will increase a person’s likelihood of developing Type 2 Diabetes Mellitus
(Escott-Stump, 2008).

Overweight and Obesity
An increase in adipose tissue results in cells becoming more resistant to insulin
(American Diabetes Association, 2011a). People that are classified as overweight with a
BMI of at least 25.0 kg/m2 but less than 30.0 kg/m2, or obese with a BMI of 30.0 kg/m2
or higher, are at greater risk for developing Type 2 Diabetes Mellitus (Escott-Stump,
2008). Physical activity helps control body weight, uses glucose as energy, and makes the
cells more sensitive to insulin; thus, inactivity may lead to Diabetes Mellitus (American
Diabetes Association, 2011a). A high-density lipoprotein (HDL) cholesterol value of less
than 35 mg/dL, a low-density lipoprotein (LDL) value greater than 100 mg/dL, a
triglyceride level greater than 250 mg/dL, and hypertensive blood pressure of 140/90 mm
Hg or higher are all associated with an increased risk for developing Type 2 Diabetes
Mellitus (Table 3) (Escott-Stump, 2008).

15

Table 3.

Recommendations for Lipid and Blood Pressure Levels for Adults with
Diabetes Mellitus

High-Density Lipoprotein Cholesterol

> 35 mg/dl

Low-Density Lipoprotein Cholesterol

< 100 mg/dl

Triglycerides

< 250 mg/dl

Blood Pressure

< 140/90 mm Hg

Source: American Diabetes Association, 2007b.

Racial/Ethnic Minorities
It is unclear why certain racial/ethnic groups (African Americans, Hispanic
Americans, Native Americans, Asian Americans, and Pacific Islanders) historically are at
a higher risk for developing Type 2 Diabetes Mellitus compared to Caucasians (EscottStump, 2008). Signorello et al. (2007) suggested that differences in racial/ethnic
prevalence of diabetes may occur due to differences in socioeconomic status.

Gestational Diabetes Mellitus
Women that experienced Gestational Diabetes Mellitus during pregnancy or
delivered a baby weighing greater than nine pounds have an increased likelihood of
developing Type 2 Diabetes Mellitus later in life (Escott-Stump, 2008).

Complications of Diabetes Mellitus
Uncontrolled or untreated Diabetes Mellitus will affect every organ system within
the body and may lead to damaging complications such as blindness, kidney damage,
heart disease, hypertension, and limb amputations. Long-term complications of poorly
managed Diabetes Mellitus include macrovasular diseases, which are diseases of the
16

large blood vessels, and microvascular diseases that involve the small blood vessels
causing nephropathy and retinopathy. Diabetes Mellitus is the leading cause of kidney
disease and new cases of blindness among adults aged 20 to 74 years (Centers for
Disease Control and Prevention, 2011). Data from 2004 indicated that heart disease was
reported in 68 percent of all Diabetes Mellitus-related deaths in people over the age of 65
years, and stroke was the major cause of death for people over 65 years of age with
Diabetes Mellitus (Centers for Disease Control and Prevention, 2011).
Approximately 67 percent of people with Diabetes Mellitus have hypertension
with blood pressure values that equals or exceeds 140/90 mm Hg (Centers for Disease
Control and Prevention, 2011). The treatment for hypertension in persons with Diabetes
Mellitus should be proactive to reduce the risk of macrovascular and microvascular
complications. Being hypertensive can decrease insulin release which will lead to higher
blood glucose levels (Franz et al., 2002). If intense medical nutrition therapy for three
months does not reduce the systolic and diastolic blood pressures, then pharmacologic
agents should be implemented (American Diabetes Association, 2006).
Controlling blood pressure can reduce the risk of heart disease and stroke by 33 to
50 percent, and reduce microvascular disease by 33 percent (Escott-Stump, 2008). For
every 10-mm Hg decrease in systolic blood pressure, the risk for any complication related
to Diabetes Mellitus is reduced by 12 percent (Escott-Stump, 2008). However, there
appears be no benefit in reducing the systolic blood pressure below 140 mm Hg (Centers
for Disease Control and Prevention, 2011). When the diastolic blood pressure is reduced
from 90 to 80 mm Hg, this is associated with a 50 percent reduction in the risk of major
cardiovascular events (Centers for Disease Control and Prevention, 2011).
17

More than 28 percent of people with Diabetes Mellitus over the age of 40 have
diabetic retinopathy (Centers for Disease Control and Prevention, 2011). Advanced
retinopathy may lead to severe loss of vision; there are 655,000 cases of retinopathy in
people with Diabetes Mellitus (Centers for Disease Control and Prevention, 2011). There
are approximately 12,000 to 24,000 new cases of blindness each year (American Diabetes
Association, 2006). Optimal control of blood glucose and blood pressure can
substantially reduce the risk and progression of diabetic retinopathy (American Diabetes
Association, 2006). Of the people who have Type 2 Diabetes Mellitus for 20 years or
more, approximately 60 percent of them have some degree of retinopathy (American
Diabetes Association, 2006).
In the United States, diabetic nephropathy has become the most common cause of
end-stage renal disease, and accounts for almost 40 percent of new cases of end-stage
renal disease (American Diabetes Association, 2004). People with Type 2 Diabetes
Mellitus comprise more than half of all people currently on renal dialysis (American
Diabetes Association, 2004). In 2008, there were over 48,000 people with Diabetes
Mellitus that began receiving treatment for end-stage renal disease (Centers for Disease
Control and Prevention, 2011). Over 200,000 patients with Diabetes Mellitus in 2008
were either living with chronic kidney disease receiving dialysis or waiting for a kidney
transplant (Centers for Disease Control and Prevention, 2011). When kidney disease is
detected early, controlling blood pressure can reduce the decline in kidney function by 30
to 70 percent (Centers for Disease Control and Prevention, 2011).
The earliest evidence of nephropathy is the appearance of low urine albumin
levels, or microalbuminuria. The onset of end-stage renal disease is typically about five
18

years after microalbuminuria is present in the urine (American Diabetes Association,
2006). Although diabetic nephropathy cannot be cured, strict glucose management and
reduction in blood pressure will decrease the progression of nephropathy (American
Diabetes Association, 2006).
Chronic high levels of blood glucose are associated with 60 to 70 percent of
people with Diabetes Mellitus having nerve damage or neuropathy (Pastors, Warshaw,
Daly, Franz, & Kulkarni, 2002). Peripheral neuropathy affects the nerves that control the
feeling in the hands and feet. Autonomic neuropathy affects the nerve functioning that
controls the organ systems (Franz, 2008).
Almost 30 percent of people with Diabetes Mellitus over the age of 40 years have
impaired sensation in their feet (Centers for Disease Control and Prevention, 2011),
which can lead to amputation of limbs. In 2006, there were over 65,000 non-traumatic
lower-limb amputations in people with Diabetes Mellitus, which accounted for more than
60 percent of all lower-limb amputations (Centers for Disease Control and Prevention,
2011). Neuropathy may be delayed with strict blood glucose management (American
Diabetes Association, 2006). Neuropathy is most common in obese patients, thus weight
management or weight loss is beneficial to delay or prevent the effects of neuropathy
(American Diabetes Association, 2006). Being aggressive in treatment and working with
healthcare professionals to control levels of blood glucose, blood pressure, hypertension,
blood lipids will help decrease complications of the disease.
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United Kingdom Prospective Diabetes Study
The United Kingdom Prospective Diabetes Study Group (1998) was a trial that
demonstrated a distinct link between strict glycemic control and the development of
diabetic complications. This study involved more than 5,000 people who were newly
diagnosed with Type 2 Diabetes Mellitus and were followed for an average of 10 years.
The participants in this study were randomly selected to be in one of two groups:
intensive therapy or conventional therapy. The group that received intensive therapy
reduced microvascular complications by 25 percent and macrovascular disease by 16
percent (United Kingdom Prospective Diabetes Study Group, 1998).
Nutrition therapy at diagnosis is very important for control of Diabetes Mellitus.
Before the participants were randomized in the United Kingdom Prospective Diabetes
Study Group (1998), each received individualized nutrition education for three months.
During this time, the mean HbA1c dropped by 1.9 percentage points with a modest
weight loss of eight pounds. It was concluded that the reduction in energy consumption
was just as important in controlling blood glucose levels as the weight loss experienced
by most of the participants (United Kingdom Prospective Diabetes Study Group, 1998).
Diabetes Mellitus is a progressive disease and therapy will need to be adjusted
and intensified as the disease progresses. Medical nutrition therapy alone will not keep
patients’ HbA1c levels below seven percent as the disease progresses. It is not the diet
that is failing; it is the pancreas’ ability to secrete enough insulin to maintain adequate
glucose control, and thus, oral medications and/or insulin are needed with strict dietary
management (United Kingdom Prospective Diabetes Study Group, 1998). To best
manage Diabetes Mellitus, therapies must include medical nutrition therapy, physical
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activity, blood glucose monitoring, medications, and self-management education. The
overall goal is to equip the person with tools, skills, and knowledge to best achieve
glycemic, lipidemia, and blood pressure control to either prevent or delay the onset of
microvascular and macrovascular disease complications (United Kingdom Prospective
Diabetes Study Group, 1998).

Evidence of Medical Nutrition Therapy in Diabetes Management
The term “medical nutrition therapy” was coined in 1994 by the American
Dietetic Association to better communicate the nutrition therapy process (Pastors et al.,
2002). Medical nutrition therapy is used to assess the nutritional status of the person and
effectively treat the person whether it is with nutrition therapy, counseling, or nutrition
supplements (Pastors et al., 2002). When medical nutrition therapy is practiced in
accordance with Diabetes Mellitus management, it has four processes:
1. Assessment of the patient’s nutrition and Diabetes Mellitus self-management
knowledge and skills
2. Identification and negotiation of individually designed nutrition goals
3. Nutrition intervention involving a careful match of both a meal-planning approach
and educational materials to meet the person’s needs, with flexibility in mind so
the plan can be implemented by the person
4. Evaluation of outcomes and ongoing monitoring (Pastors et al., 2002)
Medical nutrition therapy plays an integral role in Diabetes Mellitus management.
There is not one single diet that can be prescribed for all people with Diabetes Mellitus.
In order for medical nutrition therapy to be effectively implemented, it must be a team
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approach that includes a registered dietitian that is knowledgeable and skilled at
implementing the recommendations and guidelines for Diabetes Mellitus management.
When medical nutrition therapy is provided in combination with self-management
training, it is associated with a one to two percentage point decrease in HbA1c levels in
people with Type 2 Diabetes Mellitus (Lemon et al., 2004; Pastors et al., 2003). The
effectiveness of the training will be known three months after HbA1c has been obtained;
at that time the registered dietitian may need to assess whether the goals of the therapy
will continue to be appropriate for the person. To evaluate the success of medical
nutrition therapy, blood glucose monitoring, HbA1c, blood pressure, and lipid panels
must all be evaluated.
The goal of medical nutrition therapy with people that have Type 2 Diabetes
Mellitus is to achieve blood glucose, lipid, and blood pressure levels within normal limits
to reduce the risks of vascular diseases. It is important to slow down, if not prevent, the
development of chronic complications of Diabetes Mellitus by modifying food intake and
lifestyle (American Diabetes Association, 2007b). Individual nutritional needs, lifestyle,
cultural preferences, and willingness to change should be accounted for in a nutrition
prescription for Diabetes Mellitus management (American Diabetes Association, 2007b).
Food choices should only be limited based on evidence that the foods will increase blood
glucose levels, but the overall goal should still be to maintain pleasurable eating. The
basis of all nutritional recommendations as related to Diabetes Mellitus is to improve
food choices but to continue pleasurable eating experiences (American Diabetes
Association, 2007b).
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Lemon et al. (2004) conducted a study that examined people with Type 2
Diabetes Mellitus that received nutrition education from a registered dietitian at baseline,
and additional nutrition education sessions at the discretion of the dietitian. All subjects
received face-to-face counseling according to the facility’s policy. It was reported that
weight, glycemic control, coronary heart disease risk, and self-management behaviors
were all significantly improved from baseline to six months. During the six months,
weight loss was 6.2 ± 14.6 pounds, HbA1c reduction was 1.7 ± 2.0%, and reduction in
risk of coronary heart disease was 3.5 ± 6.1% (Lemon et al., 2004).
Banister, Jastrow, Hodges, Loop, and Gillham (2004) composed a group of 70
adults with Type 2 Diabetes Mellitus to study the effect of community clinic education to
lower HbA1c levels. The group attended a four-hour education class and attended
Diabetes Mellitus support group meetings for at least two months and up to 12 months.
The class education consisted of the: definition of Diabetes Mellitus, role of insulin,
target ranges for blood glucose and HbA1c levels, symptoms of hypoglycemia and
hyperglycemia, nutrition education, exercise, and foot care procedures. The results of the
program indicated an average of a one percentage point drop in HbA1c levels in the
participants (Banister et al., 2004).

Diabetes Mellitus and Diet

Carbohydrates
The preferred terms for carbohydrates include sugars, starch, and fiber (American
Diabetes Association, 2007a). It may seem that a low-carbohydrate diet would be
appropriate for managing Diabetes Mellitus but the American Diabetes Association
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(2006) states that low-carbohydrate meal plans are not recommended in the management
of Diabetes Mellitus. There are numerous factors that will influence a glycemic response
to carbohydrates, including the amount of carbohydrates, types of sugars, nature of the
starch, food processing, and the blood glucose level prior to consumption of
carbohydrates (American Diabetes Association, 2007a). The priority for meal planning
should be the total amount of carbohydrate that a person eats for meals and snacks.
Carbohydrate counting is a commonly used method for meal planning with Diabetes
Mellitus. Carbohydrates are the primary nutrient that affects the postprandial blood
glucose and insulin levels. Carbohydrates are measured in grams and servings; one
carbohydrate serving is approximately 15 grams of carbohydrate. Carbohydrate intake
should comprise approximately 45 to 65 percent of the total daily energy intake (Franz,
2008).

Protein
Protein does not increase the plasma glucose concentration in people with
controlled Diabetes Mellitus (American Diabetes Association, 2006). Protein should
comprise 15 to 20 percent of daily energy intake of people with Diabetes Mellitus with
normal renal function (Sargrad, Homko, Mozzoli, & Boden, 2005). When weight loss is
needed, using a slightly higher recommendation of protein may help to enhance insulin
sensitivity (Sargrad et al., 2005). High-protein diets are not recommended for people with
Diabetes Mellitus (American Diabetes Association, 2006).
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Dietary Fat
Due to lack of evidence, the goal of dietary fat consumption for people with
Diabetes Mellitus should be the same recommendations as people with a history of
cardiovascular disease (American Diabetes Association, 2007a). The total fat intake
should not exceed 25 to 35 percent of the total energy consumed daily. The saturated fat
intake should be less than seven percent and the intake of trans-fat should either be
eliminated or minimized (American Diabetes Association, 2007a). Reducing the amount
of fried and creamed foods that a person with Diabetes Mellitus consumes will help
decrease the intake of saturated and trans-fat (Escott-Stump, 2008). To reduce total
cholesterol and LDL-cholesterol levels, one should reduce the consumption of saturated
and trans-fatty acids. Studies indicate that a high-monounsaturated-fat diet seems to have
a favorable effect on fasting lipoprotein profiles in people with Diabetes Mellitus (EscottStump, 2008).

Alcohol
The same alcohol precautions that apply to the healthy population apply to people
with Diabetes Mellitus. Daily alcohol consumption should be limited to one drink for
women and two drinks for men. A moderate amount of alcohol consumption has a
minimal effect on glucose and insulin levels (Howard, Arnsten, & Gourevitch, 2004).
Each alcoholic drink contains approximately 15 grams of carbohydrates. Alcoholic
beverages should be consumed as part of a regular meal plan for people with Diabetes
Mellitus (American Diabetes Association, 2007a). Food should not be omitted when
alcohol is consumed because it may induce alcohol hypoglycemia (Howard et al., 2004).
25

Alcohol does not require insulin to be present to be metabolized, which may lead to
alcohol-induced hypoglycemia (Howard et al., 2004). Light to moderate alcohol
consumption (one to two drinks per day) is associated with a decrease in the risk of
coronary heart disease in people with Diabetes Mellitus because the alcohol increases
HDL-cholesterol levels and improves insulin sensitivity (Howard et al., 2004).

Diabetes Mellitus and Physical Activity and Exercise
Physical activity is movement of the body produced by contraction of the skeletal
muscles in which energy expenditure exceeds resting energy expenditure. Exercise is a
component of physical activity in which the activity is planned, structured, and repeated
to obtain physical fitness (Franz, 2008). Exercise and physical activity are beneficial in
people with Type 2 Diabetes Mellitus and those that are insulin resistant (Boule, Haddad,
Kenny, Wells, & Sigal, 2001). Regiments of exercise at 50 to 80 percent the maximum
amount of oxygen that an individual can utilize during exercise for 30 to 60 minutes three
to four times a week has been shown to lower HbA1c levels by one to two percentage
points (Sigal, Kenny, Wasserman, Castaneda-Sceppa, & White, 2004).
Blood glucose control can improve with exercise due to a decrease in insulin
resistance and an increase in insulin sensitivity in persons with Type 2 Diabetes Mellitus
(Boule et al., 2001). This decreased resistance to insulin, and increased sensitivity to
insulin, will result in increased peripheral use of glucose not only during exercise, but
after exercise (Boule et al., 2001). As the muscles work, this causes insulin levels to
decline during exercise while glucagon rises. Exercise enhances insulin sensitivity, which
occurs independently of any effect on body weight, and decreases the effects of counter26

regulatory hormones, which in turn reduces the hepatic glucose output leading to
improved glucose control (Boule et al., 2001). Exercise also effectively reduces
triglyceride levels in people with Type 2 Diabetes Mellitus (Boule et al., 2001).
Over 30 percent of Mississippi residents are considered to be physically inactive
(Centers for Disease Control and Prevention, 2008c). In Webster County, Mississippi,
over 31 percent of its residents were reported to be physically inactive. With the high
prevalence of Diabetes Mellitus in Webster County, physical activity may lead to better
control of HbA1c levels. By being physically active, this can lead to weight loss and
improved BMI levels.

Diabetes Mellitus and Obesity
Obesity and Diabetes Mellitus are two of the top public health problems in the
United States (Figures 4 and 5) (Centers for Disease Control and Prevention, 2011). Both
Diabetes Mellitus and obesity are major causes of morbidity and mortality in the United
States (Mokdad et al., 2003). Evidence indicates that obesity and weight gain are
associated with increased risk of Diabetes Mellitus, and intentional weight loss reduces
the risk of developing Diabetes Mellitus (Mokdad et al., 2003). Overweight and obesity
are determined by one’s BMI (kg/m²). An adult that has a BMI of 25.0 to 29.9 is
considered overweight, and an adult that has a BMI of 30 or greater is classified as obese
(National Heart, Lung, and Blood Institute, 1998). Over the past 20 years, the United
States has suffered from a dramatic increase in obesity rates with only Colorado and the
District of Columbia having obesity prevalence rates below 20 percent (Centers for
Disease Control and Prevention, 2011). There are 33 states with obesity rates of more
27

than 25 percent, and nine states have greater than 30 percent of their population classified
as obese (Centers for Disease Control and Prevention, 2011). Mississippi has a high
prevalence of obesity and over 33 percent of adults in Mississippi are considered obese
(Trust for America’s Health, 2011).

Figure 3.

Prevalence Estimates of Obesity and Diabetes Mellitus in the United
States.

Source: Centers for Disease Control and Prevention, 2007.
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Figure 4.

Percentage Estimates of Obesity in the United States.

Source: Centers for Disease Control and Prevention, 2008c.

From 1991 to 2001, there was a 74 percent increase in obesity and a
corresponding 61 percent increase in persons diagnosed with Diabetes Mellitus (Mokdad
et al., 2003). In 2001, 3.4% of adults in the United States were both obese and diagnosed
with Diabetes Mellitus (Mokdad et al., 2003). There are at least 44 million adults (23
million women and 21 million men) classified as obese; and this number is often underreported (Mokdad et al., 2003). Obesity is an epidemic that needs to be aggressively
treated as it can lead to Type 2 Diabetes Mellitus and other serious medical conditions
(Franz, 2008). Type 2 Diabetes Mellitus and obesity are often both preventable with
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modest lifestyle changes (Mokdad et al., 2003). When changes are made such as
increasing physical activity and eating a balanced diet, Diabetes Mellitus and obesity
rates can be greatly reduced (Mokdad et al., 2003). Health professionals must continue to
stress the importance of consuming a healthy, well balanced diet and regular physical
activity as the best ways to promote weight loss (Mokdad et al., 2003).
There must be a team effort to effectively manage Diabetes Mellitus. The person
with Diabetes Mellitus needs to be at the center of this relationship because they have the
responsibility of managing their day-to-day activities. The nurses, doctors, dietitians, and
pharmacists all contribute their knowledge to developing regiments that will help the
person achieve metabolic control. The goal is to provide the person with knowledge,
skills, and motivation to self-manage their Diabetes Mellitus. Individuals with Diabetes
Mellitus should receive individualized medical nutrition therapy as needed to meet their
treatment goals (American Diabetes Association, 2011b). In people who are insulin
resistant, a modest weight loss of five to seven percent of their current weight has been
shown to reduce insulin resistance (American Diabetes Association, 2011b). Medical
nutrition therapy is an integral component of Diabetes Mellitus prevention and
management. The American Diabetes Associations recognizes nutrition as an essential
component of Diabetes Mellitus self management and an overall healthy lifestyle
(American Diabetes Association, 2011b).
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CHAPTER III
METHODOLOGY

Purpose of Study
The purpose of this retrospective study was to investigate the effectiveness of the
Diabetes Mellitus Education Class at NMMC-Eupora based on HbA1c levels among
class participants. The BMI levels were also documented as this indicates obesity, and
obesity is a contributing factor for the prevalence of Diabetes Mellitus. This study
evaluated the effectiveness of Diabetes Mellitus education provided at NMMC-Eupora as
evidenced by HbA1c levels at three months, six months, and 12 months after attending
class. The BMI levels were recorded within one month prior to attending Diabetes
Mellitus education class and again at three months, six months, and 12 months after
attending class.

Hypotheses
HO1: There will not be a significant change in HbA1c levels among people
attending Diabetes Mellitus Education Class at three months, six months, or 12 months
post class attendance.
HO2: There will not be a significant change in BMI levels among people attending
Diabetes Mellitus Education Class at three months, six months, or 12 months post class
attendance.
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H1: There will be a significant change in HbA1c levels among people attending
Diabetes Mellitus Education Class at three months, six months, or 12 months post class
attendance.
H2: There will be a significant change in BMI levels among people attending
Diabetes Mellitus Education Class at three months, six months, or 12 months post class
attendance.

Participants
The subjects for this study consisted of 46 people diagnosed with Type 2 Diabetes
Mellitus who attended Diabetes Mellitus Education Class at NMMC-Eupora. All
participants must be referred by their medical doctor to attend the education class. This
facility is located at 70 Medical Plaza, Eupora, Mississippi. This study was conducted
from participants that attended class between May 2008 and December 2009.

Procedure
The Diabetes Mellitus Education Class at NMMC-Eupora offers extensive
Diabetes Mellitus education and personalized meal plans to people diagnosed with
Diabetes Mellitus. This study focused exclusively on participants with Type 2 Diabetes
Mellitus. The staff for the class consists of a Diabetes Nurse Educator and a Registered
Dietitian. In order to provide Diabetes Mellitus education, the educators must have at
least 15 hours of continuing education in Diabetes Mellitus. The class is under the
direction of the medical staff at NMMC-Eupora. This is an 8-hour one day class that
focuses on effectively managing Diabetes Mellitus. The class is conducted at NMMCEupora in the education facility. Teaching methods include power point lectures, food
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models, and personal interaction. A summary of each class is sent to the participant’s
personal healthcare provider.
The Diabetes Mellitus Education Class is designed for people with newly
diagnosed Diabetes Mellitus that would benefit from education on basic Diabetes
Mellitus management. Diabetes Mellitus requires comprehensive education to be
successfully managed. The Diabetes Mellitus Education Class provides information to
allow participants to easily make adaptable changes to their current lifestyle. The class
targets specific areas of Diabetes Mellitus management such as blood glucose monitoring
and evaluation, recognizing and treating low blood glucose, sick day treatment, meal
planning, and foot and eye care recommendations. A Registered Dietitian provides
nutrition education and meal plans that are tailored to meet each person’s nutritional
needs within the guidelines provided by the American Heart Association, the American
Dietetic Association, and the American Diabetes Association.
The class is conducted the third Wednesday of each month. In order for the class
to meet, there must be at least two physician-referred participants in attendance. The class
begins at 8:00 in the morning and lasts approximately eight hours. Class participation
averages three to six members; this allows for each participant to receive individualized
attention. Upon arrival each participant is asked to complete a 24-hour food recall stating
portion sizes and the time of day that foods and beverages are consumed, and to also
identify specific areas of nutrition they would like to gain additional knowledge. A pretest is given by the Diabetes Nurse Educator to identify each participant’s understanding
of Diabetes Mellitus (Appendix A). Power point lectures consisting of nursing care,
complications and sick days, physical activity, pharmacy and medication basics, and
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stress/emotions are presented by the Diabetes Nurse Educator. Participants are
encouraged to ask questions about any of the topics that are discussed, or other questions
about managing Diabetes Mellitus.
Participants have their feet checked for peripheral neuropathy by the Diabetes
Nurse Educator. People with uncontrolled Diabetes Mellitus may experience decreased
feeling in their feet, which can lead to complications (Franz, 2008). Each participant
receives education about the importance of foot care for people with Diabetes Mellitus.
The nurse works with each participant to establish a personalized self glucose
monitoring schedule. Each participant is asked to closely monitor their blood glucose
levels for a period of time after attending class. The Diabetes Nurse Educator discusses
the post class blood glucose values with the participants; if blood glucose levels are not
improving, medications are adjusted to aid in achieving blood glucose levels within
normal limits. This continued education as provided by the nurse serves as reinforcement
to what was taught in the Diabetes Mellitus Education Class.
The Registered Dietitian provides education related to healthy eating and
carbohydrate counting. Power point presentations, food models, and group discussions
are the teaching methods used by the Registered Dietitian. Copies of the presentations are
provided to each participant to take home. Personalized meal plans are provided to the
participants prior to discussing carbohydrate counting. Meal plans are developed taking
into consideration each participant’s gender, height, weight, and personal eating habits.
The meal plan is divided into four sections (breakfast, lunch, supper, and snacks). Within
each meal and snack there are serving size recommendations for proteins, carbohydrates
(which include starch, fruit and milk) and fats. The Registered Dietitian explains in detail
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how carbohydrates affect blood glucose levels. Limiting, but not excluding,
carbohydrates from the diet is emphasized through portion control of foods containing
carbohydrates.
Lunch is provided to each class participant and is served in the hospital cafeteria.
All participants are encouraged to follow the new meal plans that have been provided to
them by the Registered Dietitian. After the lunch meal, there is class discussion in which
each participant identifies the carbohydrates, proteins, and fats that were consumed. The
lunch meal is then compared to each individualized meal plan to determine if the
participant was able to correctly follow the prescribed meal plan.
A post test is conducted at the end of the Diabetes Mellitus Education Class to
determine if participants’ knowledge of Diabetes Mellitus improved (Appendix A).
Contact information for both the Diabetes Nurse Educator and Registered Dietitian are
provided to each participant. Participants are encouraged to call the nurse and dietitian
with questions they may have after attending Diabetes Mellitus Education Class.
Continued education is important in the management of Diabetes Mellitus.
Participants are referred by their physicians for Diabetes Mellitus Education Class and
the cost of this class is covered by most insurance agencies. Because the insurance
company pays either the full or partial cost of attending the class, a participant can only
attend the class as dictated by their health insurance. For most insurance companies, this
means that a patient is allowed to attend Diabetes Mellitus Education Class no more than
one time in a calendar year. The Diabetes Mellitus Education Class taught at NMMCEupora is recognized by the American Diabetes Association as meeting the standards for
Diabetes Mellitus education. When a Diabetes Mellitus Education Class meets the
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standards set forth by the national standards of Diabetes Mellitus Self Management
Education and is recognized by the American Diabetes Association, the education class is
reimbursable as part of Medicare programs (American Diabetes Association, 2011b).
Additionally, when medical nutrition therapy for Diabetes Mellitus is delivered by a
Registered Dietitian according to the nutrition practice guidelines, it is reimbursable as
part of Medicare programs (American Diabetes Association, 2011b).
Institutional Review Board Approval
Project approval was obtained prior to starting this study from the Institutional
Review Board (IRB) through the Mississippi State University (MSU) Regulatory
Compliance Office, Mississippi State, Mississippi (Appendix B). The IRB of North
Mississippi Health Services of Tupelo, Mississippi, also provided IRB approval for the
study (Appendix C). Data collection was conducted at NMMC-Eupora in Eupora,
Mississippi, which is affiliated with North Mississippi Health Services of Tupelo,
Mississippi. Hospital policy requires IRB approval for all research studies including those
that use information from medical records.

Data Collection
HbA1c values, weights, heights, age, gender, and race were entered onto an Excel
spreadsheet (Microsoft Corp., 2007, Redmond, WA) using medical records of
participants who attended Diabetes Education Class at NMMC-Eupora. Participants had
follow-up visits where their HbA1c levels and weights were documented. Heights and
weights were used to hand calculate BMI values using the equation BMI = kg/m2.
Weights and heights were converted to metric units (kilograms and meters) since the
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weights and heights were recorded in the medical records as pounds and inches. The
HbA1c blood values were collected and analyzed in the hospital’s laboratory, and
recorded in the individual’s medical record at three months, six months, and 12 months
after the individual attended class; however, sometimes participants did not return for all
of their follow-up appointments.
Statistical Analysis
Data were analyzed using the Statistical Package for Social Sciences software,
version 18.0 (SPSS, Inc., Chicago, IL). Baseline data for HbA1c and BMI levels were
compared using paired t-tests for the three follow-up visits at three months, six months,
and 12 months post class attendance. Correlation coefficients were examined to
investigate relationships between HbA1c and BMI levels. This study was not able to
track all participants who attended the Diabetes Mellitus Education Class due to some
participants missing follow-up appointments. At least one blood HbA1c value and one
BMI value were documented for each participant post class attendance. All available data
were used for analysis. A control group was not available. Significance levels were set at
P ≤ 0.05. Continuous variables are reported as means ± standard deviations (SD).
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CHAPTER IV
RESULTS AND DISCUSSION

This retrospective study was conducted with the Diabetes Mellitus Education
Class at NMMC-Eupora, Mississippi, to evaluate the effectiveness of Diabetes Mellitus
education based on HbA1c levels of 46 participants. Results indicated significant
differences (P < 0.05) in outcomes of HbA1c values at three months, six months, and 12
months post class attendance. This study indicated that the null hypothesis, there will not
be a significant change in HbA1c levels among people attending Diabetes Mellitus
Education Class at three months, six months, or 12 months post class attendance, can be
rejected. There were no significant (P > 0.05) differences in outcomes of BMI values at
three months, six months, or 12 months post class attendance. Therefore the null
hypothesis, there will not be a significant change in BMI levels among people attending
Diabetes Mellitus Education Class at three months, six months, or 12 months post class
attendance, cannot be rejected.
There were 25 female and 21 male participants (Table 4). Most of the participants
were Caucasians (n = 29) with 15 Caucasian women who had an age range of 29 to 71
years; Caucasian men (n = 14) had an age range of 36 to 84 years; African American
women (n = 10) had an age range of 40 to 71 years, and the seven African American men
had an age range of 32 to 60 years. The mean age of the participants was 54.8 years ±
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13.0 SD (Table 4). Only 3 participants were less than 40 years old, 15 were 40 to 49
years old, 11 were aged 50 to 59 years, and 17 were 60 years and older. The mean weight
was 104.4 kg ± 27.6 SD with a range of 61.8 to 194.5 kg. The height ranged from 152.4
to 198.1 cm with a mean of 168.9 cm ± 10.8 SD. The mean BMI was 36.7 kg/m2 which
indicated obesity per BMI classification guidelines of the National Heart, Lund, and
Blood Institute (1998). None of the participants were classified as underweight, three had
normal BMI values, six were overweight, and 37 were classified as obese with BMI’s
ranging from 30.1 to 67.1 kg/m2 (Table 5).
Table 4.

Baseline Characteristics of Participants

Characteristic

Participants (N = 46)

Age (yrs)

54.8 ± 13.0 (29 – 84)a

Weight (kg)

104.4 ± 27.6 (61.8 – 194.5)

Height (cm)

168.9 ± 10.8 (152.4 – 198.1)

BMIb (kg/m2)
Gender
Race
a

36.7 ± 9.7 (22.9 – 67.1)
25 females
21 males
17 African Americans
29 Caucasians

Mean ± standard deviation (range)
Body mass index

b
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Table 5.

Baseline Body Mass Index Classification of Participants

BMIa Category

Males (n=21)

Females (n=25)

Underweight
0
(< 18.5)
Normal
1 African American
(18.5 – 24.9)
1 Caucasian
Overweight
3 Caucasians
(25.0 – 29.0)
Obese
6 African Americans
(> 30.0)
10 Caucasians
a
Body mass index, calculated as kg/m2

0
1 Caucasian
2 African Americans
1 Caucasian
8 African Americans
13 Caucasians

The HbA1c concentrations allow those in the medical profession to determine if a
person is controlling their Diabetes Mellitus. The HbA1c concentration provides a
definitive assessment as it measures the overall effectiveness of blood glucose control
during an average 3-month period. The HbA1c values for people with Diabetes Mellitus
should be less than seven percent (American Diabetes Association, 2007b). The results
from this study indicated that the mean HbA1c level at baseline was elevated at 9.5% ±
2.4 (N = 46). The mean HbA1c level at three months was 8.1% ± 2.1 and was
significantly lower compared to the baseline HbA1c (P = 0.002, n = 31). The six-month
HbA1c value was also significantly lower compared to the baseline HbA1c value and
was 8.1% ± 2.6 (P = 0.001, n = 39). The 12-month HbA1c value, as compared to the
baseline HbA1c level, was lower at 8.7% ± 2.3 (P = 0.050, n = 29) (Table 5). Although
the three-month, six-month, and 12-month HbA1c levels were lower compared to the
baseline level (P < 0.05), these levels were still higher than the recommended level of
less than seven percent for people with Diabetes Mellitus.
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Although the mean HbA1c level increased from 8.1% at six months to 8.7% at 12
months, it was not a significant increase (P > 0.05) (Table 6). Figure 5 presents a time
series of the participants’ HbA1c levels. It clearly shows a decrease (P < 0.05) in HbA1c
levels from baseline to three months, and then there is a non-significant increase (P >
0.05) from six to 12 months (Figure 5). Brown (1992) reported similar results from a
meta-analysis of Diabetes Mellitus education. Individuals with Diabetes Mellitus
received education about Diabetes Mellitus self-management skills including weight loss
and healthy HbA1c levels; results indicated that HbA1c levels improved between one and
six months post education but after six months, the HbA1c levels started to rise. Length
of the educational intervention did not appear to affect the outcome (Brown, 1992).
A meta-analysis with 18 randomized controlled trials that evaluated educational
and behavioral interventions in participants (n = 2720) with Type 2 Diabetes Mellitus
with a mean age of 57 years, and follow-up from one to 26 months, reported a reduction
in HbA1c of 0.43% (P = 0.003) (Gary, Genkinger, Guallar, Peyrot, & Brancati, 2003).
The investigators concluded that, “Previous educational and behavioral interventions in
type 2 diabetes have produced modest improvements in glycemic control” (Gary et al.,
2003, p.488). Results of the present study also showed improvement in glycemic control
of the group of 46 participants after attending diabetes education.

Table 6.

Mean Hemoglobin A1c (HbA1c) Values for Participants
Baseline
(N = 46)

HbA1c (%)
ab

9.5a

3 months post
class attendance
(n = 31)
8.1b

6 months post
class attendance
(n = 39)
8.1b

12 months post
class attendance
(n = 29)
8.7b

Means in a row with different letters are significantly different (P ≤ 0.05)
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10
9.5
9
8.5

HbA1c

8
7.5
7
Baseline

Figure 5.

3 month

6 month

12 month

Mean Hemoglobin A1c (HbA1c) Values of Participants from Baseline to
12 months.

The decrease of HbA1c values observed in the present study are similar to results
reported by Bannister et al. (2004) who conducted a four-hour Diabetes Mellitus
education class to participants (N = 70) followed by individual dietitian consultations and
monthly support meetings. After two to 12 months of class participation, they reported a
mean HbA1c decrease of 15%, from 9.7% ± 2.6 to 8.2% ± 2.0 (Bannister et al., 2004),
which is similar to the 14.7% decrease in HbA1c observed in the present study, from
9.5% ± 2.4 at three months, and 8.1% ± 2.6 at six months. Pastors et al. (2002) review of
the United Kingdom Prospective Diabetes Study reported a decrease in HbA1c from
approximately 9 to 7% within the first few months in newly diagnosed people with Type
2 Diabetes Mellitus. There was a decrease from 9.5 to 8.1% in the first three months in
the present study (Table 6).
Lemon et al. (2004) conducted a study in which HbA1c levels and weight were
measured at baseline, three months, and six months. Over the six-month period, there was
a weight loss of 6.2 ± 14.6 pounds and a reduction in HbA1c level of 1.7% ± 2.0 (Lemon
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et al., 2004). While Lemon et al. (2004) did not report BMI values, a decrease in weight
is associated with a decrease in BMI. The present study conducted at NMMC-Eupora
revealed non-significant (P > 0.05) increases in BMI levels at three months and six
months compared to baseline (Table 7). It was only at 12 months that a decrease in BMI
was observed; however, it was not a significant decrease (P > 0.05) (Table 7). Figure 7
shows the mean BMI value rise from baseline to three months (P > 0.05) and then fall
from three months to six and 12 months (P > 0.05).

Table 7. Mean Body Mass Index Values of Participants
Baseline
(N = 46)
BMIa (kg/m2)
a

36.7

3-months post
6-months post 12-months post
class attendance class attendance class attendance
(n = 29)
(n = 37)
(n =27)
ns
ns
39.0
37.2
36.4 ns

Body Mass Index
Not significant, means were not significantly different from one another (P > 0.05)

ns

39.5
39
38.5
38
37.5
37
36.5
36
35.5
35

BMI

Baseline

Figure 6.

3 months

6 months

12 months

Mean Body Mass Index (BMI) Values of Participants from Baseline to 12
months.
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Just over three percent of the United States adult population has been diagnosed
with Diabetes Mellitus and classified as obese (Mokdad et al., 2003). In the current study,
the mean BMI at baseline for this group of people with Diabetes Mellitus was 36.7 kg/m2
± 9.7 (N = 46), which indicated obesity, as did all mean BMI values (Table 7). The threemonth BMI was 39.0 kg/m2 ± 10.4 (P = 0.406, n = 29), and the six-month BMI was 37.2
kg/m2 ± 10.4 (P = 0.488, n = 37). The 12-month mean BMI was lower at 36.4 kg/m2 ±
8.5, but it was not significant (P = 0.449, n = 27). None of the values were considered
significant at P > 0.05 (Table 7).
The BMI levels at three months, six months, and 12 months were not significantly
correlated with baseline or other HbA1c values (P ≤ 0.05). The mean BMI increased just
over two points from the baseline BMI to the three-month BMI. From baseline to the sixmonth BMI, there was half a point increase in the BMI level among participants. It
should be noted that only at 12 months post class attendance was there a non-significant
(P > 0.05) decrease in BMI and this decrease was only three-tenths of a point (Figure 8).
Mississippi has the highest prevalence of obesity in the United States (Trust for
America’s Health, 2011). The adult obesity rate is 33.8% for the state of Mississippi, and
women are the most obese gender in the state with 34.9% falling into this classification
(Trust for America’s Health, 2011). Among ethnic populations, 42.9% of African
Americans and 29.3% of Caucasians are considered obese in Mississippi (Trust for
America’s Health, 2011). In this study, 43 participants (93.5%) were classified as
overweight or obese. Two African Americans were classified as overweight and 14
(30.4%) were obese, as compared to four Caucasians who were overweight and 23
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(50.0%) were obese (Table 5). However, all participants in the study were diagnosed with
Type 2 Diabetes Mellitus, which is associated with obesity (Escott-Stump, 2008).
It is certainly not the goal of the educators that teach the Diabetes Mellitus
Education Class to see an increase in BMI levels. A consensus algorithm determined
when oral medications or insulin therapy is initiated in the treatment of Diabetes Mellitus,
an association can be made with weight gain in the initial phases of the therapy (Nathan
et al., 2009). Numerous Diabetes Mellitus medications, specifically sulfonylureas,
thiazolidinediones, and insulin, are associated with weight gain upon initiation (Nathan et
al., 2009). A weight gain of approximately two kilograms is associated with the initiation
of sulfonylurea therapy and a two- to four-kilogram weight gain upon initiation of insulin
therapy (Nathan et al., 2009). Medications are essential in the management of Diabetes
Mellitus even if weight gain is an initial side effect. Working with the class participants
to achieve a healthy BMI may help manage Diabetes Mellitus more effectively.
Guo, Zeller, Chumlea, and Siervogel (1999) determined that BMI significantly
increases with age. Generally there is an age-related increase in BMI for both men and
women from the age of 40 to 65 years (Guo et al., 1999). Although there were no
significant correlations between gender, HbA1c values, or BMI (P > 0.05), there was a
significant negative correlation between age and BMI (r = - 0.355, P = 0.016, N = 46) in
the current study. However, while only three (6.5%) of the participants were less than 40
years old, 13 participants (28.3%) were older than 65 years in the current study.
Diabetes Mellitus is common, chronic, and controllable. Good management of
Diabetes Mellitus depends on the person’s discipline to manage this lifelong disease.
Good Diabetes Mellitus management is evidenced by HbA1c levels below seven percent.
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Type 2 Diabetes Mellitus is managed through healthy food choices, physical activity,
maintaining a healthy weight, and taking medication(s) as prescribed. The treatment for
Type 2 Diabetes Mellitus may change over a lifetime. Diabetes Mellitus management
will always include continued education, healthy eating, blood glucose monitoring, and
physical activity no matter the person’s age or duration of Diabetes Mellitus. It is through
HbA1c testing that a picture is painted of Diabetes Mellitus control. The HbA1c levels
should be checked at least twice a year but good management of Diabetes Mellitus would
indicate having an HbA1c checked every three months.
The Diabetes Mellitus Education Class at NMMC-Eupora provides detailed
education in all areas of Diabetes Mellitus management. Healthy eating is paramount in
the management of Type 2 Diabetes Mellitus. By working with a Registered Dietitian, a
proper meal plan can lead to better control as evidenced by HbA1c levels within normal
ranges, and may even lead to better weight management. Choosing healthy foods can
help keep blood glucose levels within the target range. The Centers for Disease Control
and Prevention (2011) reported that 16 percent of adults diagnosed with Type 2 Diabetes
Mellitus manage their Diabetes Mellitus through nutrition intake. When a diet is high in
fat, this usually leads to weight gain which may result in increased risk of a heart attack
and Diabetes Mellitus. By having a modest weight loss, this can lead to major gains in
health. Even with a small amount of weight loss, this may lead to lower blood glucose
and HbA1c levels. Regular physical activity can help people with Type 2 Diabetes
Mellitus lose weight, lower the risk of heart disease, possibly reduce the use of
medication, and increase overall health and well being (American Diabetes Association,
2011b).
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Participants that attended Diabetes Mellitus Education Class at NMMC-Eupora
did not receive education about weight loss. Each participant was provided with a
personalized meal plan that indicated a caloric restriction, which was intended for the
person to lose weight. Each participant was encouraged to make healthy food choices that
included many low-fat food choices. Participants were encouraged to consume fruits and
vegetables as part of a healthy meal plan because fruits and vegetables provide fiber and
healthy nutrients. Instead of choosing to eat a pastry or other high-calorie snacks that may
be within the person’s allowed carbohydrate intake, the participants were taught benefits
of choosing low-calorie snacks to improve eating habits. These healthy eating tips were
not presented as dieting or promoting weight loss, but were incorporated into the person’s
overall healthful eating plan.
Complications that stem from Diabetes Mellitus were also discussed in the class.
Both short- and long-term complications, if not managed properly, can lead to difficulty
in managing Diabetes Mellitus. By working together, people with Diabetes Mellitus and
their support network can reduce the occurrence of complications resulting from poorly
managed Diabetes Mellitus. Nutrition, physical activity, oral medications, and insulin are
key tools in the management of Diabetes Mellitus. When oral medications and/or insulin
are taken appropriately, it will typically result in better control of Diabetes Mellitus and
lowering HbA1c levels. HbA1c is the best test to determine tight control of Diabetes
Mellitus. This is a key indicator to a medical professional if the Diabetes Mellitus
management tools that were taught during the Diabetes Mellitus Education class are
being followed. Continued education is a key ingredient to maintaining or achieving
HbA1c levels within normal limits.
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CHAPTER V
CONCLUSION

The number of people with Diabetes Mellitus in the United States is increasing
and is predicted to continue to increase within the next few decades. Adults over the age
of 65 are the largest age group of people diagnosed with Diabetes Mellitus in 2010
(Centers for Disease Control and Prevention, 2011). With the number of cases of
Diabetes Mellitus expected to increase by 165% by the year 2050 in the United States
(Diabetes Foundation of Mississippi, 2010), it is important to deliver programs that help
people with Diabetes Mellitus effectively manage their disease, especially in Mississippi
which has a high prevalence of Diabetes Mellitus.
T he parameters of the this study established that not all participants were
consistent in having their HbA1c checked every three months, although the importance of
this was discussed while attending the Diabetes Mellitus Education Class. Having HbA1c
levels checked every three months, trends are easier to follow and changes and
adjustments to the meal plan and/or medications can be made, which can lead to better
control of Diabetes Mellitus. All medical professionals need to encourage people with
Diabetes Mellitus to have their HbA1c checked on a routine basis (American Diabetes
Association, 2011b).
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This study determined that after participants attended the Diabetes Mellitus
Education Class, their HbA1c levels were reduced at three months, six months, and 12
months. Although the HbA1c levels remained above the American Diabetes Association
recommendation of seven percent or below; there was a significant decrease (P < 0.05) in
HbA1c levels at three months, six months, and 12 months compared to baseline. By
attending the Diabetes Mellitus Education Class at NMMC-Eupora, participants and
caregivers were provided education about the basics of Diabetes Mellitus management.
When food and medication(s) are consumed correctly, this is typically associated with
improved HbA1c levels (Franz, 2008). This class provides each person with the tools
they need to effectively manage their Diabetes Mellitus whether they are healthy,
exercising, or sick.
To improve the Diabetes Mellitus Education Class at NMMC–Eupora, there
should be a focus on weight loss. People with Type 2 Diabetes Mellitus can usually
benefit from a modest weight loss of five to seven percent of their current weight
(American Diabetes Association, 2011b). This small weight loss may lead to the cells
being more sensitive to insulin which will lead to overall better control of Diabetes
Mellitus (American Diabetes Association, 2011b). Weight loss is recommended for
overweight and obese individuals with Type 2 Diabetes Mellitus (American Diabetes
Association, 2011b). The Diabetes Mellitus Education Class prepares the participants to
manage Diabetes Mellitus through healthy food intake but is lacking in teaching the
participants the importance of weight loss, and healthy benefits associated with weight
loss.
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Continued Diabetes Mellitus education is imperative for any person to
successfully manage this disease (Pastors et al., 2003). Comprehensive Diabetes Mellitus
education cannot be accomplished in one 8-hour class. Participants need continuous
follow-up with the physicians, nurses and dietitians. This study supports the position of
the American Diabetes Association (2007a) that nutrition education aids in lowering
HbA1c levels. However, the results of this study cannot be generalized to other people
with Diabetes Mellitus. There is a need for further research related to Diabetes Mellitus
management and nutrition education.
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APPENDIX A
PRE- AND POST-TEST FOR DIABETES MELLITUS EDUCATION CLASS
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7. Monitoring should be done more
often…
a. on sick days
b. when traveling
c. when meal or exercise plans
change
d. at all of the above times

NAME__________________________
1. Insulin helps the body
a. turn sugar into energy
b. get rid of sugar in the blood
c. store sugar in the blood
d. both a and b

8. Regular exercise may
a. lower blood glucose
b. reduce the amount of insulin
needed
c. reduce the amount of diabetes
pills needed
d. do all of the above

2. Insulin is made in the
a. liver
b. stomach
c. kidneys
d. pancreas
3. Complications of diabetes include
a. kidney disease
b. eye problems
c. foot problems
d. all of the above

9. During illness you should stop taking
your medications
a. True
b. False

4. Diabetes pills
a. lower blood glucose
b. increase the release of insulin
c. fight insulin resistance
d. do all of the above

10. Which of the following can affect
blood sugar control?
a. stress
b. eating habits
c. exercise
d. all of the above

5. All patients with diabetes follow the
same meal plan.

11. To decrease dietary fat and
cholesterol, which food is the best
choice?
a. steak
b. fried eggs
c. broiled chicken without skin
d. ham and cheese sandwich

a. True
b. False
6. For avoidance of hypoglycemia, the
best time to exercise is
a.
b.
c.
d.

anytime you are hungry
just before dinner
after meals
just before breakfast
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12. Which of the following is a symptom
of hypoglycemia?
a. weakness
b. sweating
c. shakiness
d. all of the above
13. Which of the following foods is a
low fat protein source?
a. broiled flounder
b. Swiss cheese
c. Carrots
d. Saltines
14. If alcohol is allowed, you should
drink it
a. on an empty stomach
b. along with food
15. A good source of complex
carbohydrates is
a. eggs
b. mayonnaise
c. whole-grain bread
d. roast beef
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February 18, 2011
Amy Farnsworth
140 Cedar Lane
Starkville, MS 39759
RE: IRB Study #11-046: Effectiveness of Diabetes Education for Managing Hemoglobin
A1c Levels in Adults
Dear Ms. Farnsworth:
This email serves as official documentation that the above referenced project was
reviewed and approved via administrative review on 2/18/2011 in accordance with 45
CFR 46.101(b)(4). Continuing review is not necessary for this project. However, any
modification to the project must be reviewed and approved by the IRB prior to
implementation. Any failure to adhere to the approved protocol could result in suspension
or termination of your project. The IRB reserves the right, at anytime during the project
period, to observe you and the additional researchers on this project.
Please note that the MSU IRB is in the process of seeking accreditation for our human
subjects protection program. As a result of these efforts, you will likely notice many
changes in the IRB's policies and procedures in the coming months. These changes will
be posted online at http://www.orc.msstate.edu/human/aahrpp.php.
A signed formal approval letter will only be mailed at your request. Please refer to your
IRB number (#11-046) when contacting our office regarding this application.
Thank you for your cooperation and good luck to you in conducting this research project.
If you have questions or concerns, please contact me at cwilliams@research.msstate.edu
or call 662-325-5220.
Sincerely,
Christine Williams, CIP
IRB Compliance Administrator
cc: Diane Tidwell (Advisor)
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